September 22, 2021 13:53 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Asaduddin Owaisi's house vandalised in Delhi, 5 members of Hindu Sena arrested | Three members of a family die in waterlogged home near Kolkata trying to charge phone | US opening an 'era of relentless diplomacy' after Afghanistan: Joe Biden at UNGA session | Air Marshal VR Chaudhari to be next Indian Air Force chief | Nitin Gadkari emphasises on fixing driving hours for truck drivers of commercial vehicles
Serum Institute says Covishield production increased to 110 million doses in July Covishield
Image Credit: SII Twitter

Serum Institute says Covishield production increased to 110 million doses in July

India Blooms News Service | @indiablooms | 13 Jul 2021, 06:09 pm

Pune/IBNS: Serum Institute of India (SII) said Tuesday the production of Covishield has been ramped up to 110 million doses this month, according to media reports.

"The commitment to produce 100-110 million doses of Covishield by July has been achieved," Serum Institute sources told NDTV.

Additionally, SII is also going to produce Russia's Sputnik V vaccine from September and it is also gearing up to rollout of the Covovax (Novavax) vaccine, which is yet to get Emergency Use Authorisation.

Currently, Covishield and Covaxin are the two vaccines used in India's massive Covid-19 vaccination drive.

The Central government aims to vaccinate all adults by the end of 2021.